Migration of human lymphocytes. I. A model using the mouse as host.
The distribution of radioactivity after the intravenous injection of 51Cr-labelled human lymphocytes has been examined in normal mice, irradiated mice, mice treated with anti-platelet antiserum and in mice treated with colloidal carbon. Pre-treatment with carbon and anti-platelet antiserum appears to protect the human lymphocytes from uptake by the host's reticuloendothelial system (RES). Comparison of tissue radioactivity in carbon-treated mice after the injection of viable human lymphocytes with that found after the injection of dead cells and soluble or insoluble cell debris showed that radioactivity recovered in the spleen and lymph nodes is primarily due to the migration of viable lymphocytes into these tissues. Thus the measurement of radioactivity in lymph nodes of carbon-treated mice after the injection of 51Cr-labelled human lymphocytes can be used as a model of these lymphocytes' ability to migrate into the lymph nodes during recirculation and to study factors influencing this migration.
D000818:Animals; D001792:Blood Platelets / Q000502:physiology; D002244:Carbon / Q000494:pharmacology; D002465:Cell Movement / Q000187:drug effects / Q000528:radiation effects; D002860:Chromium Radioisotopes; D003102:Colloids; D005260:Female; D005720:Gamma Rays; D006358:Hot Temperature; D006801:Humans; D008198:Lymph Nodes / Q000166:cytology; D017710:Lymphocyte Transfusion; D008214:Lymphocytes / Q000276:immunology / Q000502:physiology*; D051379:Mice; D008954:Models, Biological; D013154:Spleen / Q000166:cytology; D014018:Tissue Distribution; D014183:Transplantation, Heterologous
D002860:Chromium Radioisotopes; D003102:Colloids; D002244:Carbon